These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3223978)

  • 21. Competition of drugs to serum albumin in combination therapy.
    Sułkowska A; Bojko B; Równicka J; Sułkowski W
    Biopolymers; 2004 Jun; 74(3):256-62. PubMed ID: 15150801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, refolding, and isotopic labeling of human serum albumin domains for NMR spectroscopy.
    Mao H; Gunasekera AH; Fesik SW
    Protein Expr Purif; 2000 Dec; 20(3):492-9. PubMed ID: 11087689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-protein interactions. Comparative studies of levamisole and structural analogs or agents with immunomodulatory effect on the mechanism of protein aggregation.
    Chicault M; Luu-Duc C; Boucherle A
    Arzneimittelforschung; 1990 Jan; 40(1):55-7. PubMed ID: 2340000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of colchicine with human serum albumin investigated by spectroscopic methods.
    Hu YJ; Liu Y; Zhao RM; Qu SS
    Int J Biol Macromol; 2005 Nov; 37(3):122-6. PubMed ID: 16239027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of eupatilin-human serum albumin interactions by means of spectroscopic and computational modelling.
    Tang J; Lian N; Bi C; Li W
    J Pharm Pharmacol; 2007 May; 59(5):637-43. PubMed ID: 17524228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.
    Zhu L; Yang F; Chen L; Meehan EJ; Huang M
    J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
    Lucas LH; Price KE; Larive CK
    J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of human serum albumin with bendroflumethiazide studied by fluorescence spectroscopy.
    Pang YH; Yang LL; Shuang SM; Dong C; Thompson M
    J Photochem Photobiol B; 2005 Aug; 80(2):139-44. PubMed ID: 15916901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the interaction between palmatine hydrochloride and human serum albumin by fluorescence quenching method.
    Wang YQ; Zhang HM; Zhang GC
    J Pharm Biomed Anal; 2006 Jun; 41(3):1041-6. PubMed ID: 16549318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the interaction of aglycon of daunorubicin with human serum albumin by spectroscopy and modeling.
    Cui F; Qin L; Zhang G; Yao X; Lei B
    Macromol Biosci; 2008 Dec; 8(12):1079-89. PubMed ID: 18785686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface-enhanced Raman spectroscopy study of the interaction of the antitumoral drug emodin with human serum albumin.
    Fabriciova G; Sanchez-Cortes S; Garcia-Ramos JV; Miskovsky P
    Biopolymers; 2004 May-Jun 5; 74(1-2):125-30. PubMed ID: 15137109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide.
    Zech SG; Eldredge HB; Lowe MP; Caravan P
    Inorg Chem; 2007 Apr; 46(9):3576-84. PubMed ID: 17425306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMR study of the interactions between flurazepam and human serum albumin. The nature of the complexation site on the benzodiazepin molecule.
    Sarrazin M; Sari JC; Bourdeaux-Pontier M; Briand C
    Mol Pharmacol; 1979 Jan; 15(1):71-7. PubMed ID: 34091
    [No Abstract]   [Full Text] [Related]  

  • 36. Spectroscopic and molecular modeling studies of the interaction between cytidine and human serum albumin and its analytical application.
    Cui F; Wang J; Yao X; Wang L; Zhang Q; Qu G
    Biopolymers; 2007 Oct 5-15; 87(2-3):174-82. PubMed ID: 17657711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone].
    Seeling A; Oelschläger H; Rothley D
    Pharmazie; 2000 Apr; 55(4):293-6. PubMed ID: 10798243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site.
    Ahmad B; Parveen S; Khan RH
    Biomacromolecules; 2006 Apr; 7(4):1350-6. PubMed ID: 16602760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 19F NMR spectroscopic study on the binding of triflupromazine to bovine and human serum albumins.
    Kitamura K; Kume M; Yamamoto M; Takegami S; Kitade T
    J Pharm Biomed Anal; 2004 Oct; 36(2):411-4. PubMed ID: 15496337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saturation transfer difference nuclear magnetic resonance study on the specific binding of ligand to protein.
    Ji Z; Yao Z; Liu M
    Anal Biochem; 2009 Feb; 385(2):380-2. PubMed ID: 19070584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.